Skip to content
Open access

Human P301L tau expression in mice alters neuronal excitability independent of neurodegeneration

Sep 2026 · Frontiers in Neuroscience · Vol 20 · 0 citations · 56 references
Medicine

TL;DR

Data suggest an increase in neuronal excitability in P301L mice compared with WT, but that this phenotype is not correlated with the age-dependent accumulation of AT8-labeled tau aggregates and the accompanying neuroinflammation.

Abstract

Variation in the microtubule-binding protein tau is causally implicated in numerous neurodegenerative diseases, including Alzheimer’s disease. However, the mechanisms by which such variation results in disease are not well understood. The JNPL3(P301L) mouse model mimics the effects of the P301L mutation on human tau associated with frontotemporal dementia. As previously reported, phospho-tau aggregates immunolabeled with AT8 increase with age in a rostral progression from the brainstem; however, there is relatively limited forebrain pathology by the time these animals die prematurely at approximately 1 year of age. In this study, we investigated the functional effects of P301L tau expression on electrophysiological signatures as a function of age in mice expressing P301L tau from 3 to 10 months. The P301L mice had a distinct electrophysiological phenotype of increased power in higher EEG frequency bands detected with a depth electrode in the hippocampus and, to a lesser extent, with dural surface electrodes over the frontal and parietal cortices. Significantly, this electrophysiological phenotype was present at the first recording at 3 months of age and did not differ over monthly recordings up to 9 months of age, after which point animals became moribund and were euthanized. P301L mice at 10 months of age also showed electrical synchronization to a 40 Hz tone (ASSR) that was not observed in WT mice and an increase in inter-trial coherence compared with WT mice. We confirmed that AT8, as well as markers of neuroinflammation, increased progressively with age from the hindbrain to the forebrain, as previously reported. Together, these data suggest an increase in neuronal excitability in P301L mice compared with WT, but that this phenotype is not correlated with the age-dependent accumulation of AT8-labeled tau aggregates and the accompanying neuroinflammation. We hypothesize that the expression of P301L mutant tau disrupted the physiological functions of tau, resulting in the functional electrophysiological phenotype. Whether this functional effect drives neurodegeneration or is a separable phenomenon has implications for understanding the mechanisms underlying the role of tau variation in neurodegenerative conditions.

Read PDF

Similar papers

Feb 2026

Pathogenic tau in the mouse locus coeruleus produces noradrenergic hyperactivity and neuropsychiatric phenotypes reminiscent of early Alzheimer’s disease

It is demonstrated that pTau triggers phenotypes reflective of LC-NE hyperactivity in the early stages of AD pathogenesis, laying the foundation for the development of LC-based disease-modifying therapies to address neuropsychiatric manifestations.

Anuradha Korukonda, Harris E. Blankenship, K. Kam et al. · 3 citations
Open access Aug 2026

Differential amyloid-beta sensitivity across human and nonhuman primate neurons.

The human brain has undergone a threefold increase in size as well as changes in cytoarchitecture and neurochemical organization since the split with the last common ancestor with chimpanzees and bonobos. These changes have likely promoted increased cognitive flexibility but may also have come at the cost of increased...

Isabel August, Sheila Steiner, Ruth Oefner et al. · 0 citations
Open access Aug 2026

Activated microglial phenotypes in the hippocampal CA2 subfield are implicated in Lewy body disease progression

The data show that activated microglial phenotypes in the CA2 of LBD patients are associated with worse clinical outcomes and retrograde n-asyn transmission, and suggest that measures of microglial states can refine LBD histopathological progression models.

Esteban Luna, K. Cousins, Sheina Emrani et al. · 0 citations
Oct 2026

Differential effects of amyloid-β and tau on UCH gene expression in Drosophila models of Alzheimer's disease.

BACKGROUND Alzheimer's disease (AD) is a common neurodegenerative disorder characterized by progressive impairments in learning and memory. Substantial evidence indicates that dysfunction of the ubiquitin-proteasome system (UPS) in the AD brain leads to aberrant protein aggregation, ultimately resulting in synaptic dys...

Mohammad Javad Arayesh, Fatemeh Ataellahi, R. Masoudi · 0 citations
Open access Sep 2026

Altered Membrane Protein Abundance in the Cerebral Cortex of the JNPL3 Mouse Model of Tauopathy

Developing effective therapeutic approaches for tau-associated neurodegenerative diseases, including frontotemporal dementia and Alzheimer’s disease, remains extremely challenging due to their complex pathogeneses. Membrane proteins constitute a large proportion of current therapeutic and drug delivery targets becaus...

S. Petralla, Jooseppi Hyvärinen, Mikko Gynther et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.